Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Pyrotinib|DRUG: Epirubicin|DRUG: Cyclophosphamide|DRUG: Taxanes|BIOLOGICAL: Trastuzumab
Sponsor: Hebei Medical University Fourth Hospital